News
February 12, 2025 Research and Development
The establishment of World's first "CADASIL Drug Discovery Research Department" in collaboration with National Cerebral and Cardiovascular Center
Pharma Foods International Co., Ltd. (Hereinafter: PFI) and National Cerebral and Cardiovascular Center (Head Office: Suita City, Osaka Prefecture, Chairperson: Kinya Otsu, Heareinafter: NCVC) will jointly establish the world's first "CADASIL Drug Discovery Research Department" with the aim of developing a therapeutic agent for the treatment of CADASIL, a designated intractable disease.
(PDF, 308KB)